Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia

Anti-angiogenic therapy is emerging as a valuable tool in the treatment of patients with cancer. As VEGF is a central target in anti-angiogenic therapy, its levels in the circulation might be relevant in selecting tumor types or patients likely to respond to this treatment. Additional VEGF has been...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kusumanto, Yoka H., Meijer, Coby, Dam, Wendy, Mulder, Nanno H., Hospers, Geke A.P.
פורמט: Artigo
שפה:Inglês
יצא לאור: Libertas Academica 2007
נושאים:
Review
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155238/
https://ncbi.nlm.nih.gov/pubmed/21901067
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים